Comparative effects of rosiglitazone and metformin on fatty liver and visceral adiposity in type 2 diabetes mellitus

被引：0
|
作者：
Kelley, DE
Mckolanis, TM
Kelley, CA
机构：
来源：
DIABETES | 2002年 / 51卷
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
142
引用
收藏
页码：A35 / A35
页数：1
相关论文
共 50 条
  • [1] Comparative effects of rosiglitazone and metformin on fatty liver and visceral adiposity in Type 2 diabetes mellitus
    Kelley, DE
    McKolanis, TM
    Kelley, CA
    DIABETOLOGIA, 2002, 45 : A188 - A188
  • [2] Rosiglitazone plus metformin to prevent type 2 diabetes mellitus
    Ferrante, Giuseppe
    Zavalloni, Dennis
    Corrada, Elena
    Presbitero, Patrizia
    LANCET, 2010, 376 (9750): : 1387 - 1388
  • [3] The use of a combination of metformin and rosiglitazone in type 2 diabetes mellitus
    Demidova, T. Y.
    DIABETES MELLITUS, 2007, 10 (03): : 27 - 31
  • [4] The effects of rosiglitazone and metformin on inflammation and endothelial dysfunction in patients with type 2 diabetes mellitus
    Evren Fidan
    H. Onder Ersoz
    Mustafa Yilmaz
    Hulya Yilmaz
    Mustafa Kocak
    Caner Karahan
    Cihangir Erem
    Acta Diabetologica, 2011, 48 : 297 - 302
  • [5] The effects of rosiglitazone and metformin on inflammation and endothelial dysfunction in patients with type 2 diabetes mellitus
    Fidan, Evren
    Ersoz, H. Onder
    Yilmaz, Mustafa
    Yilmaz, Hulya
    Kocak, Mustafa
    Karahan, Caner
    Erem, Cihangir
    ACTA DIABETOLOGICA, 2011, 48 (04) : 297 - 302
  • [6] The effects of rosiglitazone and metformin on the plasma concentrations of resistin in patients with type 2 diabetes mellitus
    Jung, HS
    Youn, BS
    Cho, YM
    Yu, KY
    Park, HJ
    Shin, CS
    Kim, SY
    Lee, HK
    Park, KS
    METABOLISM-CLINICAL AND EXPERIMENTAL, 2005, 54 (03): : 314 - 320
  • [7] Rosiglitazone plus metformin to prevent type 2 diabetes mellitus Reply
    Zinman, Bernard
    LANCET, 2010, 376 (9750): : 1388 - 1388
  • [8] Fatty liver in type 2 diabetes mellitus: relation to regional adiposity, fatty acids, and insulin resistance
    Kelley, DE
    McKolanis, TM
    Hegazi, RAF
    Kuller, LH
    Kalhan, SC
    AMERICAN JOURNAL OF PHYSIOLOGY-ENDOCRINOLOGY AND METABOLISM, 2003, 285 (04): : E906 - E916
  • [9] Visceral fat thickness predicts fatty liver in Koreans with type 2 diabetes mellitus
    Kim, Hai Jin
    Cho, Min Ho
    Park, Jong Suk
    Nam, Ji Sun
    Kang, Eun Seok
    Ahn, Chul Woo
    Cha, Bong Soo
    Lee, Eun Jig
    Lim, Sung Kil
    Kim, Kyung Rae
    Lee, Hyun Chul
    Huh, Kap Bum
    JOURNAL OF KOREAN MEDICAL SCIENCE, 2008, 23 (02) : 256 - 261
  • [10] Effects of rosiglitazone and metformin treatment on apelin, visfatin, and ghrelin levels in patients with type 2 diabetes mellitus
    Kadoglou, Nikolaos P. E.
    Tsanikidis, Hercules
    Kapelouzou, Alkistis
    Vrabas, Ioannis
    Vitta, Ioulia
    Karayannacos, Panayotis E.
    Liapis, Christos D.
    Sailer, Nikolaos
    METABOLISM-CLINICAL AND EXPERIMENTAL, 2010, 59 (03): : 373 - 379
12345